Popularity #218Ex-dividend in 3d · $0.72
Medtronic (MDT)
Builds medical devices for cardiac, neurological, surgical, and patient-monitoring care.
$90.80
After hours+0.03 (+0.03%)
At close$90.77(−1.07%)
In millions of USD, except per-share figures
| In millions | Q2 FY24Oct 2023 | Q3 FY24Jan 2024 | Q4 FY24Apr 2024 | Q1 FY25Jul 2024 | Q2 FY25Oct 2024 | Q3 FY25Jan 2025 | Q4 FY25Apr 2025 | Q1 FY26Jul 2025 | Q2 FY26Oct 2025 | Q3 FY26Jan 2026 | Q4 FY26Apr 2026 | Q1 FY27Jul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,984 | 8,089 | 8,589 | 7,915 | 8,403 | 8,292 | 8,927 | 8,578 | 8,961 | 9,018 | 9,807 | 9,756 |
| Cost of revenue | 2,761 | 2,782 | 3,044 | 2,761 | 2,946 | 2,779 | 3,147 | 3,632 | 3,556 | 3,166 | 2,367 | 3,416 |
| Gross profit | 5,223 | 5,307 | 5,545 | 5,154 | 5,457 | 5,513 | 5,780 | 4,946 | 5,405 | 5,851 | 7,441 | 6,340 |
| 3,883 | 3,824 | 4,492 | 3,876 | 3,862 | 3,867 | 4,344 | 3,501 | 3,720 | 4,078 | 5,880 | 4,576 | |
| Research & development | 698 | 695 | 675 | 676 | 697 | 675 | 684 | 726 | 754 | 722 | 671 | 771 |
| Selling, general & administrative | 2,686 | 2,673 | 2,765 | 2,655 | 2,757 | 2,717 | 2,720 | 2,806 | 2,966 | 2,955 | 3,057 | 3,198 |
| Other expenses | 499 | 456 | 1,052 | 545 | 408 | 475 | 940 | −31 | 0 | 401 | 2,150 | 607 |
| Operating income | 1,340 | 1,483 | 1,053 | 1,278 | 1,595 | 1,646 | 1,436 | 1,445 | 1,685 | 1,773 | 1,564 | 1,764 |
| −27 | −11 | −197 | −10 | −36 | −106 | −175 | −143 | −89 | −369 | 270 | 5 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33 | 0 | 121 | −154 | 0 |
| Interest expense | 180 | 188 | 202 | 167 | 209 | 179 | 174 | 176 | 181 | 181 | 177 | 186 |
| Other non-operating income | −153 | −177 | −4 | −157 | −173 | −73 | 1 | −32 | −92 | 188 | −448 | −191 |
| Income before tax | 1,313 | 1,472 | 856 | 1,268 | 1,559 | 1,540 | 1,261 | 1,302 | 1,596 | 1,404 | 1,834 | 1,769 |
| Income tax expense | 402 | 135 | 197 | 220 | 281 | 237 | 199 | 255 | 215 | 254 | 575 | 289 |
| Net income from continuing operations | 911 | 1,337 | 659 | 1,048 | 1,278 | 1,303 | 1,062 | 1,047 | 1,381 | 1,150 | 1,259 | 1,480 |
| Other adjustments | 0 | 0 | −1 | −1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | −1 |
| Net income | 909 | 1,322 | 654 | 1,042 | 1,270 | 1,294 | 1,057 | 1,040 | 1,374 | 1,143 | 1,243 | 1,470 |
| EPS, basic | $0.68 | $0.99 | $0.49 | $0.81 | $0.99 | $1.01 | $0.82 | $0.81 | $1.07 | $0.89 | $0.98 | $1.15 |
| EPS, diluted | $0.68 | $0.99 | $0.49 | $0.80 | $0.99 | $1.01 | $0.82 | $0.81 | $1.07 | $0.89 | $0.96 | $1.14 |
| Weighted average shares, basic | 1,330 | 1,330 | 1,322 | 1,293 | 1,282 | 1,282 | 1,282 | 1,282 | 1,282 | 1,282 | 1,282 | 1,280 |
| Weighted average shares, diluted | 1,332 | 1,332 | 1,325 | 1,297 | 1,287 | 1,286 | 1,288 | 1,287 | 1,288 | 1,288 | 1,288 | 1,285 |
| EBITDA | 2,165 | 2,309 | 1,711 | 2,097 | 2,443 | 2,403 | 2,275 | 2,225 | 2,366 | 2,490 | 2,637 | 1,955 |
| Depreciation & amortization | 672 | 649 | 654 | 662 | 675 | 684 | 840 | 748 | 589 | 905 | 625 | 0 |
| EBIT | 1,493 | 1,660 | 1,057 | 1,435 | 1,768 | 1,719 | 1,435 | 1,477 | 1,777 | 1,585 | 2,012 | 1,955 |